Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

Communications medicine·2026

Same author

[Cabozantinib - unresectable or metastatic well-differentiated pancreatic and extra-pancreatic neuroendocrine tumors after at least one prior line of systemic therapy other than somatostatin analogues].

Bulletin du cancer·2026

Same author

[<sup>177</sup>Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

The Lancet. Oncology·2026

Same author

Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical Carcinomas.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same author

Safety of biopsy in phaeochromocytoma and paraganglioma: an international, multicentre, retrospective cohort study.

The lancet. Diabetes & endocrinology·2026

Same journal

[18F]F-DOPA and [18F]F-FDG PET/CT for staging advanced medullary thyroid cancer.

Annales d'endocrinologie·2026

Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026

Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026

Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026

Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026

Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 23, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

ENDOCAN TUTHYREF network consensus recommendations: Anaplastic thyroid cancer.

Livia Lamartina¹, Arnaud Jannin², Myriam Decaussin-Petrucci³

¹Département d'imagerie médicale, service de cancérologie endocrinienne, Gustave-Roussy, 94805 Villejuif, France.

Annales D'Endocrinologie

|May 11, 2025

Summary

This summary is machine-generated.

Anaplastic thyroid cancer (ATC) is aggressive. Prompt diagnosis and multidisciplinary care are crucial for managing this rare disease, with new targeted treatments offering future hope.

Keywords:

Immunotherapy Molecular biology Palliative care Refractory thyroid cancer Targeted therapy

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Related Experiment Videos

Last Updated: May 23, 2025

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Area of Science:

Oncology
Endocrinology

Background:

Anaplastic thyroid cancer (ATC) is a rare, aggressive endocrine neoplasm with a poor prognosis.
Clinical suspicion arises from rapid growth and stony neck masses, necessitating urgent diagnostic work-up.

Framework:

Management requires a multidisciplinary team approach, including specialists, support care, and geriatric oncology if needed.
Assessment must consider disease extent, comorbidities, patient's overall health, and personal preferences.

Implementation:

Realistic prognostic information should be provided to patients and families.
Treatment strategies include active therapy alongside supportive care or exclusive palliative care from diagnosis.

Implications:

Despite challenges, advances in tumor molecular profiling, targeted therapies, and immunotherapy present promising future directions for ATC management.
These consensus recommendations from the ENDOCAN TUTHYREF network offer a framework for optimizing ATC patient care.